Sign In
Buy JNJ
$231.29
+2.90 (+1.27%)
At Close: Jun 22, 2026
The Zacks Analyst Blog Duke Energy, Entergy, Constellation Brands, Coca-Cola and Johnson & Johnson
05:40am, Tuesday, 31'st Mar 2026
KO and other defensive picks stand out as market volatility spikes, with dividends, low beta, and steady growth offering a buffer in a turbulent Wall Street.
Chesley Taft & Associates LLC Buys 14,776 Shares of Johnson & Johnson $JNJ
05:12am, Tuesday, 31'st Mar 2026
Chesley Taft and Associates LLC raised its stake in Johnson and Johnson (NYSE: JNJ) by 7.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchan
Johnson & Johnson $JNJ Shares Acquired by Cypress Wealth Services LLC
05:12am, Tuesday, 31'st Mar 2026
Cypress Wealth Services LLC lifted its stake in shares of Johnson and Johnson (NYSE: JNJ) by 71.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange
Johnson & Johnson: The Return Of The Dividend King
02:03am, Tuesday, 31'st Mar 2026
Johnson & Johnson is reiterated as a buy, driven by pipeline progress and recent valuation correction. Icotyde's early FDA approval and $8B peak sales potential could add 8% annual growth to JNJ's top
This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock
12:47pm, Monday, 30'th Mar 2026
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
5 Defensive Stocks to Buy Amid Market's Recent Bloodbath
11:57am, Monday, 30'th Mar 2026
DUK, ETR, STZ, KO and JNJ emerge as defensive picks as market volatility spikes, offering stability through dividends, low beta, and steady growth strategies.
Royalty Pharma and J&J partner to develop autoimmune treatment
09:14am, Monday, 30'th Mar 2026
Royalty Pharma said on Monday it has signed a $500 million research and development agreement with Johnson & Johnson to advance an experimental antibody treatment for autoimmune diseases.
Johnson & Johnson $JNJ Shares Sold by Pallas Capital Advisors LLC
07:52am, Monday, 30'th Mar 2026
Pallas Capital Advisors LLC cut its stake in shares of Johnson and Johnson (NYSE: JNJ) by 6.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The instituti
Net Worth Advisory Group Grows Stock Position in Johnson & Johnson $JNJ
07:52am, Monday, 30'th Mar 2026
Net Worth Advisory Group increased its stake in Johnson and Johnson (NYSE: JNJ) by 24.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Dividend Investing Is Winning In 2026 - Move Over, Tech And AI
07:15am, Monday, 30'th Mar 2026
Dividend stocks and ETFs provide a safety net for investors. When the dominoes start falling, investors go risk-off and move to lower-risk assets, such as dividend stocks and ETFs. If you don't know a
CoreCap Advisors LLC Boosts Stake in Johnson & Johnson $JNJ
07:08am, Monday, 30'th Mar 2026
CoreCap Advisors LLC increased its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 120.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities
Global X Japan Co. Ltd. Has $15.96 Million Stake in Johnson & Johnson $JNJ
07:08am, Monday, 30'th Mar 2026
Global X Japan Co. Ltd. grew its position in Johnson and Johnson (NYSE: JNJ) by 289.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 77
Wealthcare Advisory Partners LLC Raises Stock Position in Johnson & Johnson $JNJ
05:54am, Monday, 30'th Mar 2026
Wealthcare Advisory Partners LLC grew its stake in shares of Johnson and Johnson (NYSE: JNJ) by 4.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities a
TABR Capital Management LLC Buys New Shares in Johnson & Johnson $JNJ
05:22am, Monday, 30'th Mar 2026
TABR Capital Management LLC purchased a new stake in shares of Johnson and Johnson (NYSE: JNJ) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and
Johnson & Johnson $JNJ Stock Position Trimmed by Avity Investment Management Inc.
03:35am, Monday, 30'th Mar 2026
Avity Investment Management Inc. cut its position in Johnson and Johnson (NYSE: JNJ) by 2.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 247,12
